This page includes the latest FDA filings for Integrated Commercialization Solutions L L C. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| Registration Number | 3002478693 |
| FEI Number | 3002478693 |
| Name | INTEGRATED COMMERCIALIZATION SOLUTIONS, LLC |
| Owner & Operator | AmerisourceBergen Corporation |
| Contact Address | 420 International Boulevard Suite 500 Brooks KY 40109 US |
| Registration Status | 1 |
| Initial Importer | Y |
| Registration Expiration | 2020-04-25 |
| Registration Address | 420 INTERNATIONAL BLVD STE 500 Brooks, KY 40109 US |
Device Company | Device | Date |
|---|---|---|
| Ferring Pharmaceuticals Inc. | Prescription Medication | 2024-02-01 |
| Ferring Pharmaceuticals Inc. | Prescription Medication | 2023-12-23 |
| MorphoSys US Inc., Boehringer Ingelheim Pharma GmbH & Co KG, BioReliance Ltd, Pacific BioLabs, Millmount Healthcare Limited (known as PCI Pharma Services), Integrated Commercialization Solutions, LLC, Morphosys US Inc | Prescription Medication | 2023-06-25 |
| MorphoSys US Inc., Boehringer Ingelheim Pharma GmbH & Co KG, BioReliance Ltd, Pacific BioLabs, Millmount Healthcare Limited (known as PCI Pharma Services), Integrated Commercialization Solutions, LLC, Morphosys US Inc | Prescription Medication | 2022-12-03 |
| Karyopharm Therapeutics Inc. | Prescription Medication | 2022-07-28 |
| Karyopharm Therapeutics Inc. | Prescription Medication | 2022-04-07 |
| Ferring Pharmaceuticals Inc. | Prescription Medication | 2022-02-15 |
| Karyopharm Therapeutics Inc. | Prescription Medication | 2021-09-25 |
| MorphoSys US Inc., Boehringer Ingelheim Pharma GmbH & Co KG, BioReliance Ltd, Pacific BioLabs, Millmount Healthcare Limited (known as PCI Pharma Services), Integrated Commercialization Solutions, LLC, Morphosys US Inc | Prescription Medication | 2021-06-08 |
| Karyopharm Therapeutics Inc. | Prescription Medication | 2021-05-20 |
| Karyopharm Therapeutics Inc. | Prescription Medication | 2020-12-19 |
| Karyopharm Therapeutics Inc. | Prescription Medication | 2020-09-16 |
| MorphoSys US Inc., Boehringer Ingelheim Pharma GmbH & Co KG, BioReliance Ltd, Pacific BioLabs, Millmount Healthcare Limited (known as PCI Pharma Services), Integrated Commercialization Solutions, LLC, Morphosys US Inc | Prescription Medication | 2020-09-10 |
| MorphoSys US Inc., Boehringer Ingelheim Pharma GmbH & Co KG, BioReliance Ltd, Pacific BioLabs, Millmount Healthcare Limited (known as PCI Pharma Services), Integrated Commercialization Solutions, LLC, Morphosys US Inc | Prescription Medication | 2020-08-05 |
| Karyopharm Therapeutics Inc. | Prescription Medication | 2020-07-02 |
| Ferring Pharmaceuticals Inc. | Prescription Medication | 2020-03-10 |
| Ferring Pharmaceuticals Inc. | Prescription Medication | 2019-09-20 |
| Karyopharm Therapeutics Inc. | Prescription Medication | 2019-08-21 |
| Karyopharm Therapeutics Inc. | Prescription Medication | 2019-07-12 |
| NCAGE Code | 3QLV7 | INTEGRATED COMMERCIALIZATION!SOLUTIONS, LLC!DBA PARAGARDDIRECT!DIV INTEGRATED COMMERCIALIZATION!SOLUTIONS, INC. |
| CAGE Code | 3QLV7 | INTEGRATED COMMERCIALIZATION SOLUTIONS, LLC PARAGARDDIRECT INTEGRATED COMMERCIALIZATION SOLUTIONS, INC. |
| S.A.M. Registration | 3QLV7 [48927672] | INTEGRATED COMMERCIALIZATION SOLUTIONS, LLC PARAGARDDIRECT |